Abstract
By harnessing the remarkable power of the immune system to access the three-dimensional chemical information sequestered in target sites for drug ligands, antibody-directed drug discovery speeds the design of new therapeutic entities.
References
Burger, A. in Burger's Medicinal Chemistry 4th Edn, Pt 1. (Ed. Wolff, M.E.) 1–54 (Wiley, New York, 1980).
DesJarlais, R.L., Sheridan, R.P., Seibel, G.L., Dixon, J.S. & Kuntz, I.D. J. med. Chem. 31, 722–729 (1988).
Walsh, C.T. Trends biochem. Sci. 8, 254–257 (1983).
Anti-idiotypes, Receptors, and Molecular Mimicry (Eds Linthicum, D.S. & Farid, N.R.) 1–154, 255–284 (Springer, New York, 1988).
McPherson, A. in The Preparation and Analysis of Protein Crystals (Wiley, New York, 1982).
Sheriff, S. et al. Proc. natn. Acad. Sci. U.S.A. 84, 8075–8079 (1987).
Geysen, H.M., Rodda, S.J., Mason, T.J., Tribbik, G. & Schoofs, P.G. J. immunol. Meth. 102, 259–274 (1987).
Williams, W.V. et al. Proc. natn. Acad. Sci. U.S.A 85, 6488–6492 (1988).
Goodman, M. Bioponymers 24, 137–155 (1987).
Kuntz, I.D. Protein Eng. (England) 1, 147–148 (1987).
Cohen, F.E., Gregoret, L., Presnell, S.R. & Kuntz, I.D. Prog. clin. biol. Res. 289, 75–85 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wolff, M., McPherson, A. Antibody-directed drug discovery. Nature 345, 365–366 (1990). https://doi.org/10.1038/345365a0
Issue Date:
DOI: https://doi.org/10.1038/345365a0
- Springer Nature Limited